| Bacterial infections in children with acute myeloid leukemia receiving ciprofloxacin prophylaxis S Al Omar, N Anabtawi, W Al Qasem, R Rihani Journal of pediatric hematology/oncology 39 (3), e131-e135, 2017 | 13 | 2017 |
| Pharmacological Inhibition of Cryptochrome and REV-ERB Promotes DNA Repair and Cell Cycle Arrest in Cisplatin-Treated Human Cells N Anabtawi, W Cvammen, MG Kemp | 12 | 2021 |
| Optimizing colistin dosing: Is a loading dose necessary? LH Nazer, N Anabtawi American Journal of Health-System Pharmacy 74 (1), e9-e16, 2017 | 12 | 2017 |
| The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature N Anabtawi, T Drabison, S Hu, A Sparreboom, Z Talebi Expert Opinion on Drug Metabolism & Toxicology 18 (7-8), 459-468, 2022 | 10 | 2022 |
| XPA is susceptible to proteolytic cleavage by cathepsin L during lysis of quiescent cells S Khan, W Cvammen, N Anabtawi, JH Choi, MG Kemp DNA repair 109, 103260, 2022 | 5 | 2022 |
| Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice AK Persaud, MC Bernier, MA Massey, S Agrawal, T Kaur, D Nayak, Z Xie, ... nature communications 14 (1), 3175, 2023 | 2 | 2023 |
| Pharmacokinetic assessment of low dose decitabine in combination therapies: Development and validation of a sensitive uhplc-ms/ms method for murine plasma analysis N Anabtawi, T Drabison, Y Jin, ED Eisenmann, A Sparreboom, ... Journal of Chromatography B, 124209, 2024 | | 2024 |
| Correction to: Increased renal elimination of endogenous and synthetic pyrimidine nucleosides in concentrative nucleoside transporter 1 deficient mice (Nature Communications … AK Persaud, MC Bernier, MA Massey, S Agrawal, T Kaur, D Nayak, Z Xie, ... Nature Communications 14 (1), 3335, 2023 | | 2023 |
| Contribution of CNT1 and CNT3 to the intestinal transport and pharmacokinetics of decitabine N Anabtawi, T Drabison, M Boeckman, Y Jin, M Halpin, AA Gibson, ... Journal of Pharmacology and Experimental Therapeutics 385 (S3), 2023 | | 2023 |
| Molecular and Clinical Features of FLT3 Juxtamembrane Domain Point Mutations (muts) in Acute Myeloid Leukemia (AML) JSB Nadeen Anabtawi, Jessica Kohlschmidt, Daelynn Buelow, Shelley Orwick ... Blood 140 (1), 6244–6246, 2022 | | 2022 |
| The Effect of Circadian Clock Modulation on Cisplatin Cytotoxicity NNA Anabtawi | | 2021 |
| A descriptive analysis of home-based therapeutic errors reported to a recently opened poison center N Anabtawi, L Amine, M Gajam, A Mohammed, KM Alansari, RJ Hoffman Journal of Emergency Medicine 58 (5), 848-849, 2020 | | 2020 |
| Energy drink warning label compliance with Qatar law L Amine, N Anabtawi, M Gajam, A Mohamed, KA Alansari, RJ Hoffman Journal of Emergency Medicine 58 (5), 848, 2020 | | 2020 |
| 1451: PREDICTORS OF AUGMENTED RENAL CLEARANCE IN CRITICALLY ILL PATIENTS WITH CANCER L Nazer, L Sheikha, N Anabtawi, J Le Critical Care Medicine 47 (1), 702, 2019 | | 2019 |
Alex SparreboomProfessor and Lucius A. Wing Chair, The Ohio State University在 osu.edu 的电子邮件经过验证
